The innate immune system needs to distinguish between harmful and innocuous stimuli to adapt its activation to the level of threat. How Drosophila mounts differential immune responses to dead and live Gram-negative bacteria using the single peptidoglycan receptor PGRP-LC is unknown. Here we describe rPGRP-LC, an alternative splice variant of PGRP-LC that selectively dampens immune response activation in response to dead bacteria. rPGRP-LC-deficient flies cannot resolve immune activation after Gram-negative infection and die prematurely. The alternative exon in the encoding gene, here called rPGRP-LC, encodes an adaptor module that targets rPGRP-LC to membrane microdomains and interacts with the negative regulator Pirk and the ubiquitin ligase DIAP2. We find that rPGRP-LC-mediated resolution of an efficient immune response requires degradation of activating and regulatory receptors via endosomal ESCRT sorting. We propose that rPGRP-LC selectively responds to peptidoglycans from dead bacteria to tailor the immune response to the level of threat.
A r t i c l e s 'Decision making' in the immune system is based on correct 'assessment' of the level of threat. The innate immune system is triggered when host pattern-recognition receptors (PRRs) encounter microbe-associated molecular patterns (MAMPs) 1,2 -conserved structural motifs, such as the bacterial cell-wall constituent peptidoglycan (PGN) 3 , that are absent from the host. Yet the PRR-MAMP conceptual framework cannot explain how the immune system distinguishes between live and dead or beneficial and pathogenic microbes. Additional immune checkpoints have been proposed that further specify immune-system decision making, such as microbial viability, virulence or proliferation 4, 5 . MAMPs derived from PGN can originate from cell-wall breakdown in dying bacteria or bacterial remodeling enzymes active during proliferation or deployment of bacterial secretion systems 6 . The enzymatically released cell-wall metabolites are anhydromuropeptides, monomeric PGN building blocks, such as tracheal cytotoxin (TCT), that are highly immunogenic 6 . PGN polymers, by contrast, are hidden under the outer lipopolysaccharide layer in Gram-negative bacteria and become accessible only upon bacterial death, as the outer membrane is impermeable to large PGN fragments 7 . How PRRs integrate information from MAMPs with different 'threat content' into a coherent immune response remains an unresolved issue.
Binding of PGN and TCT to peptidoglycan recognition receptors (PGRPs) stimulates the Drosophila immune deficiency (IMD) pathway, culminating in activation of the NF-κB-like transcription factor Relish 8 . The IMD pathway can be activated by two PGRPs, the plasma membrane-anchored PGRP-LC and the cytosolic PGRP-LE. PGRP-LC senses polymeric and monomeric breakdown products of DAP-type PGN from Gram-negative bacteria and Gram-positive bacilli [9] [10] [11] . PGRP-LC signaling is triggered by ligand-induced clustering of receptor tails, which results in the recruitment of a signaling complex, leading to activation of NF-κB 12 . The PGRP-LC gene encodes three isoforms (PGRP-LCa, PGRP-LCx and PGRP-LCy) with distinct ectodomains that differ in their capacity to bind PGN 9, 13, 14 . Detection of polymeric PGN relies on homotypic clusters of PGRP-LCx receptor isoforms alone, whereas detection of the monomeric muropeptide TCT is dependent on LCx-LCa receptor heterodimers 9, 13, 15 .
Although PGN and TCT activate the same signaling complex, their immune-response activation and resolution kinetics greatly differ. It is clear that innocuous polymeric PGN induces a more efficient resolution of immune response than TCT 13, 16 , but the underlying molecular mechanism remains unknown. PGN-triggered activation of the IMD pathway in Drosophila is regulated at multiple extra-and intracellular steps [16] [17] [18] [19] [20] [21] [22] [23] . As most negative regulators are transcriptionally controlled by the IMD pathway, they establish a feedback loop that prevents excessive activation of the immune system. However, owing to their modes of action, none of the known regulators is able to distinguish between polymeric PGN and TCT. Here we identify and characterize a regulatory PGRP-LC isoform that carries a distinct cytosolic tail predicted to bind phosphoinositides and whose specific recruitment to polymeric PGN contributes to the resolution phase of the immune response.
RESULTS

PGRP-LC encodes a cytosolic tail splice variant
In Drosophila, IMD pathway kinetics in response to Gram-negative bacteria can be assessed through monitoring the expression of the antibacterial-peptide-encoding gene Dpt, a target of the transcription factor Relish. Live and dead (heat-killed) Gram-negative bacteria introduced into flies at identical concentrations had different effects on Dpt mRNA expression, with a significantly faster return to baseline after infection with dead bacteria (Fig. 1a) . Injection of different doses of TCT triggered the IMD pathway with kinetics similar to that observed with live bacteria, consistent with TCT signaling the presence of live bacteria (Fig. 1b) . In contrast, immune responses to different doses of polymeric PGN mimicked those to dead bacteria. The resolution rate appeared to be faster after PGN than TCT at any dose, suggesting a qualitative rather than a quantitative difference in the resolution mechanism. Because both PGN and TCT engage IMD pathway adaptors through PGRP-LC, we hypothesized that the receptor itself might harbor a discriminatory mechanism to distinguish between PGN and TCT.
PGRP-LC (referred to below as LC) is a type II transmembrane receptor whose N-terminal cytosolic tail is identical in the three LC isoforms LCa, LCx and LCy 9, 24, 25 . This tail lacks endocytic motifs, and no ligand-induced trafficking of the receptor has been reported so far. A closer look at the PGRP-LC locus in FlyBase (http://flybase. org/, release FB2008_09) revealed a potential alternative first exon that might encode a functionally distinct cytosolic tail (Fig. 1c) . We termed this variant regulatory PGRP-LC (rPGRP-LC, abbreviated to rLC below). The previously unrecognized alternative exon 5 is present in the genomes of 11 out of 12 Drosophila species sequenced, with the exception of D. willistoni 26 . Exon 5 contains both a Kozak sequence upstream of the translation start codon and a splice donor site at its 3′ end (Supplementary Fig. 1a) . Similarly to the conventional exon 4, exon 5 was alternatively spliced to exons encoding the transmembrane domain and the PGRP domains x, y and a (Supplementary Fig. 1b,c) . Thus, the PGRP-LC locus gives rise to six receptor isoforms (Fig. 1c) . Transcripts containing exon 4 or exon 5 showed similar tissue specificity and expression (Fig. 1d) and comparable expression kinetics after IMD pathway challenge (Fig. 1e) , suggesting shared transcriptional control through a Relish-dependent feedback loop.
Structure-function analysis of rLC
To identify conserved motifs of rLC, we aligned its amino acid sequences from 11 Drosophila species and found two distinct conserved mRNA expression (Dpt/RpL32) A r t i c l e s domains separated by a short variable linker (Fig. 1f) . Although the linker resembled a RIP homotypic interaction motif (RHIM) in species of the melanogaster subgroup, this was not substantiated by detailed computational analysis (K. Hofmann and A. Kajava, personal communication). In silico analysis of amino acids 1-65 predicted a plant homeodomain (PHD)-type zinc finger based on a series of highly conserved cysteines arranged in a characteristic C4HC3 pattern ( Fig. 1f and Supplementary Fig. 2a) . PHD domains belong to a larger family of FYVE and RING zinc fingers, protein folds acting in protein-lipid interaction and ubiquitination, respectively 27, 28 .
The rLC PHD domain clustered with known lipid-binding adaptors, predicting a role in membrane targeting (Supplementary Fig. 2b ).
Amino acids 76-97 formed an amphipathic α-helix predicted to form coiled coils ( Supplementary Fig. 2c,d ). Circular dichroism analysis of the cytosolic region of rLC supported these structural predictions (data not shown). The predicted domain architecture of the cytosolic region of rLC suggested that this portion might mediate lipid binding, protein-protein interactions and/or homo-or heterodimerization.
rLC suppresses IMD signaling in response to polymeric PGN Next, we tested whether rLC might have a role in adjusting immune responses to different ligands. Fat body-specific overexpression of rLCx potently reduced the immune response to polymeric PGN but did not significantly suppress the TCT-induced response (Fig. 1g) . This indicated that rLCx selectively modulates the response to specific ligands. Next, we tested the ability of rLC to modulate IMD pathway activation triggered by ectopic expression of LCx. In contrast to the ability of rLC to modulate the response to specific ligands, overexpression of rLCx had no effect on IMD pathway activation triggered by overexpression of LCx, PGRP-LE or IMD (Fig. 1h) . Our data indicate, therefore, that rLC selectively modulates the response to specific ligands. To study the physiological role of the new rLC isoforms, we made use of two mutant strains: ∆LC E12 flies, which lack the PGRP-LC locus and express none of the isoforms, and ∆LC ird7(1) flies, which carry an insertion in exon 4 of PGRP-LC and consequently express only the rLC isoforms 24, 25 (Fig. 1c and Fig. 2a ). Both strains failed to induce Dpt after infection with Gram-negative bacteria and died within 2 d after infection (Fig. 2b,c) , indicating that rLC alone cannot activate the IMD pathway. We then generated a mutant lacking the rLC isoforms. For this, we complemented the ∆LC E12 mutation with engineered 'rescue' transgenes containing wild-type PGRP-LC (LCwt) 13 or PGRP-LC lacking exon 5 (LC∆ex5) (Fig. 1c) , a modification that did not affect LC expression in cis (Supplementary Fig. 3a ). Both rescue transgenes were inserted into the ϕC31 landing site at 51C on chromosome 2 ( Fig. 2d) to ensure identical transgene expression and crossed to either ∆LC E12 or ∆LC ird7(1) mutant flies ( Fig. 2e and Supplementary Fig. 3b ). The ∆LC E12 -complemented lines are referred to as resc(LCwt) and resc(LC∆ex5).
Compared to resc(LCwt) flies, resc(LC∆ex5) flies showed significantly stronger IMD pathway activation after injection of polymeric PGN, whereas the response to TCT was similar in both strains (Fig. 2f) . Next, we engineered flies carrying all possible permutations of activating isoforms LCx and LCa and regulatory isoforms rLCx and rLCa and monitored the immune response to polymeric and monomeric PGN (Fig. 2g) . As reported 13, 29 , LCx was necessary and sufficient to relay signals after polymeric PGN injection. Moreover, the response to PGN was significantly (P < 0.05) enhanced in flies lacking a c Table 1 for full genotypes) after challenge with PGN (8 h after injection, top) or TCT (24 h after injection, bottom). NS, not significant; *P < 0.05, **P < 0.01, ***P < 0.001 (one-way ANOVA, Dunnett's post hoc test (b), two-way ANOVA, Bonferroni post hoc test (f) or one-way ANOVA, Bonferroni post hoc test (g)); in c, P < 0.0001 (log-rank test). Data are pooled from three (c,f,g (top)), four (g (bottom)) or six (b) independent experiments; error bars, mean ± s.e.m.
A r t i c l e s rLCx and carrying LCx, regardless of whether LCa and rLCa isoforms were present. This indicates that rLCx is necessary and sufficient to resolve IMD activation in the presence of PGN ( Supplementary  Fig. 3c ). After TCT injection, the heterodimeric LCx-LCa module was required to relay signal, in agreement with previous work 13, 29 . However, no significant increase was observed in the absence of rLCx, rLCa or both, indicating that TCT signaling is mostly resistant to negative regulation by rLC.
Additional experiments monitoring immune activation in the whole gut (IMD signaling dependent on LC and PGRP-LE) compared to midgut (IMD signaling dependent on PGRP-LE alone) showed that the regulatory isoforms exclusively blunted LC-but not PGRP-LEactivated IMD signaling in response to indigenous gut bacteria 13, 30 ( Supplementary Fig. 3d) . Moreover, immune signaling in the fat body in the absence of infection was not significantly (P > 0.05) affected by loss of rLC (Supplementary Fig. 3d) . Collectively, our observations demonstrate that rLC isoforms function as negative regulators of LC-but not PGRP-LE-activated IMD signaling. In contrast to the action of PGRP-LF or the nonaspanins TM9SF2 and TM9SF4, which prevent LC-mediated IMD activation even in the absence of stimulus 18, 21, 31 , regulation by rLC is ligand-dependent. Most notably, rLC isoforms seem to have different effects on the immune response to polymeric and monomeric PGN-that is, to differentiate among varying levels of threat.
rLC resolves IMD activation during bacterial infection
Polymeric PGN is a post-mortem MAMP 5 that signals efficient bacterial killing. We therefore tested whether rLC could specifically curtail immune signaling in the presence of dead bacteria. Whereas flies lacking rLC isoforms killed bacteria as efficiently as wild-type flies (Fig. 3a) , they showed significant delay in resolving the immune response, despite efficient bacterial killing (Fig. 3b) . This delay was not due to the persistence of live bacteria, as the same effect was observed after challenge with heat-killed bacteria ( Fig. 3b and Supplementary  Fig. 3e ). Therefore, we conclude that rLC contributes to the resolution of the immune response by 'sensing' the presence of polymeric PGN from dead bacteria.
Despite efficient bacterial clearance, rLC mutants died significantly (P < 0.0001) earlier than wild-type controls (Fig. 3c) . Although paradoxical, this observation is in line with previous findings indicating that deregulated IMD pathway activation can result in aberrant activation of apoptotic pathways and premature death 21, 22, 32 . Likewise, mammalian TNFR signaling, which is functionally similar to the IMD pathway, induces NF-κB and MAPK cascades but also cell death 33, 34 .
Alternatively, it is possible that even small numbers of bacteria could flare up and kill the host.
Whereas loss of rLC function resulted in elevated IMD signaling, overexpression of rLCx in the fat body significantly blunted the immune response after challenge with heat-killed Gram-negative bacteria (Fig. 3d) . Accordingly, rLCx-overexpressing flies had a significantly (P = 0.0002) lower survival rate after infection with live bacteria, possibly because of insufficient IMD activation (Supplementary Fig. 3f ). Of note, fat body-specific overexpression of rLCx did not change baseline levels of Dpt expression (Fig. 3d, time  point 0) . Collectively, these data identify rLCx as a regulatory isoform of PGRP-LC that controls IMD pathway kinetics, thereby preventing lethality from unresolved immune activation.
rLC interacts with Pirk through the PHD domain We next investigated the mechanism by which rLC downregulates the IMD pathway. First we assessed the possibility that rLC regulates the availability of activating LC on the cell surface. To this end, we evaluated the levels of endogenous GFP-tagged LC (GFP-LC) in the presence (resc(LCwt)) and absence (resc(LC∆ex5)) of rLC. We found a larger accumulation of GFP-LC in rLC-deficient flies than in control flies after challenge with dead bacteria, which suggests that rLC controls the abundance of surface-exposed LC receptors (Fig. 4a) . Pirk, a negative regulator of the IMD pathway, has been reported to A r t i c l e s downregulate the surface availability of LC 17, 20, 23 . We therefore tested whether rLC interacted with Pirk and whether this interaction was required for rLC-and Pirk-mediated downregulation of IMD signaling. We noted that Pirk coimmunoprecipitated LCx and rLCx from cellular extracts (Fig. 4b) . Notably, the PHD domain of rLCx was indispensable for its interaction with Pirk, as a PHD-domain-deficient form of rLCx failed to bind to Pirk. Because Pirk can bind to different motifs in LC and rLC (RHIM and additional cytosolic motifs for LCx 17, 20, 23 and PHD for rLCx, Fig. 4b) , it is likely that Pirk's effect is mediated through binding to either receptor. Next, we assessed whether rLC and Pirk cooperate in regulating the IMD pathway upon bacterial infection. pirk-or rLC-deficient flies significantly increased the immune response as assessed by Dpt expression, and loss of both regulators was linearly additive (Fig. 4c) . Conversely, overexpression of Pirk or rLC reduced the immune response by about 50%, and combined expression of both rLC and Pirk led to a >60% decrease, albeit with no significant additive effect (Fig. 4d and Supplementary Fig. 4a) . Overexpressed rLCx was able to suppress IMD signaling in the absence of Pirk, demonstrating that Pirk is not required for rLC-mediated regulation of IMD signaling (Fig. 4e and Supplementary Fig. 4b) . Notably, overexpression of Pirk suppressed immune activation stimulated by either polymeric PGN or monomeric TCT, indicating that Pirk does not discriminate between live or dead bacteria. Thus, Pirk operates differently from rLC, with rLC exclusively regulating the response to dead bacteria (Fig. 4f) .
Together, these data indicate that despite their physical interaction, Pirk and rLC can regulate IMD activation independently of one another. Nonetheless, under physiological conditions, it is highly likely that Pirk and rLC work in concert to suppress IMD signaling by promoting extracellular, PGN-dependent and intracellular clustering of activating and regulatory receptors.
Endocytic mechanisms regulate the IMD pathway
To investigate the role of endocytic trafficking in the activation and regulation of IMD signaling, we performed a targeted mini-screen of key endocytic trafficking components in the fat body, the main organ involved in the immune response in flies (Fig. 5a and Supplementary  Tables 1 and 2) . Although none of the tested genes prevented IMD pathway activation, overexpression of dominant-negative Rab5 S43N (Rab5 DN ) and knockdown of Rab5 by RNA interference (RNAi), which disrupts the early endosomal compartment 35, 36 , each increased the amplitude and duration of IMD pathway activation. In addition, knockdown of fab1, which encodes a kinase (phosphatidylinositol 3-phosphate 5-kinase) involved in endosome maturation 37 , also led to increased activation but had no effect on resolution. Last, knockdown of vps28 (and, to a lesser, nonsignificant degree, of tsg101 and vps25), which disrupts the ESCRT complex required to traffic ubiquitinated cargo to multivesicular bodies (MVBs) 38 , extended the duration of IMD pathway activation. IMD pathway activation seemed largely clathrin and dynamin independent, as neither overexpression of dominant-negative shibire (shi DN ), the fly homolog of dynamin, nor knockdown of shi or Clc (encoding clathrin light chain) prevented Dpt induction upon Gram-negative infection. Our observation that inactivation of Rab5, Fab1 and ESCRT components results in deregulated IMD signaling suggests that accurate termination of IMD signaling requires the endocytic machinery, particularly ubiquitin-dependent removal and lysosomal degradation of a membrane-bound receptor. Fig. 4a,b) .
(f) Quantification of Dpt mRNA expression over time in flies overexpressing Pirk (UAS-pirk) in the fat body (driver and control, c564-Gal4) challenged with polymeric PGN (left) or monomeric TCT (right). *P < 0.05, **P < 0.01, ***P < 0.001 (one-way ANOVA, Tukey's post hoc test (c-e) or two-way ANOVA, Bonferroni post hoc test (f)); P < 0.0001 (log-rank test, c). Data show one representative blot from three independent experiments (b) or are pooled from three (c-e) or four (f) independent experiments (error bars, mean ± s.e.m., c-f).
A r t i c l e s
Subcellular localization of rLCx depends on the PHD domain
To test whether rLCx undergoes endocytosis, we visualized the subcellular localization of rLC in the adult fat body by overexpressing tagged versions of rLCx (Supplementary Fig. 5a ). Fat body overexpression of GFP-tagged LCx caused cell death, precluding analysis of its trafficking routes (data not shown). We overexpressed known lipidbinding probes tagged with GFP as controls. In adult fat body cells, full-length GFP-rLCx localized to discontinuous membrane domains and to perinuclear vesicles, partially mimicking the distribution of the endosomal FYVE-GFP marker ( Fig. 5b and Supplementary Fig. 5b) .
A similar distribution occurred in hemocytes, where GFP-rLCx localized to plasma membranes and intracellular vesicles and was particularly enriched at cell-cell contact sites (Supplementary Fig. 5c ). GFP-rLCx lacking the PHD domain (GFP-rLCx∆PHD) distributed more uniformly along the plasma membrane, similarly to the plasma membrane marker GFP-PLCδ-PH ( Fig. 5c and Supplementary  Fig. 5b ). This suggests that the PHD domain is involved in receptor localization to specific membrane subdomains. In fat body cells, GFPrLCx was located at membrane domains that partially overlapped with apicolateral regions (labeled by cortical actin and β-catenin, a component of adherens junctions) (Fig. 5d,e) . Taken together, these observations suggest that the PHD domain retains rLCx in specific membrane domains. Next, we tested the role of endocytosis and Pirk in regulating the localization and function of rLCx. Whereas loss of Rab5 is expected to preclude formation of endosomes and block the maturation of downstream endosomal compartments 35, 39 , loss of ESCRT machinery is expected to lead to accumulation of ubiquitinated cargo in endomembranes or to alter receptor recycling back to the plasma membrane 40 . GFP-rLCx protein accumulated in flies in which Rab5 or ESCRT components Vps28 and TSG101 were depleted ( Fig. 5f and  Supplementary Fig. 5d) . Conversely, fat body-specific overexpression of Pirk or Vps28 reduced total GFP-rLCx protein and increased the numbers of GFP-rLCx-positive vesicles (Fig. 5f-h ), suggesting Fig. 5g ). *P < 0.05, **P < 0.01, ***P < 0.001 (two-way ANOVA, Bonferroni post hoc test (a), one-way ANOVA and Dunnett's post hoc test (j, top) or KruskalWallis and Dunn's post hoc test (j, bottom). Data are from a single blot (f), are pooled from three independent experiments (a, mean ± s.e.m.) or are representative images from three independent experiments (b-e, g-i).
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A r t i c l e s enhanced endocytosis. In contrast, depletion of components of the ESCRT machinery led to a decrease in the numbers and concomitant increase in size of such vesicles (Fig. 5g,i,j and Supplementary  Fig. 5e-g ). These observations are in agreement with the idea that rLCx undergoes endocytic degradation via the ESCRT machinery, a process that is aided by Pirk.
Failure to endocytose rLC overactivates IMD signaling Given that LC accumulates in rLC-deficient flies, we tested the interdependency of rLC and ESCRT machinery in regulating LC abundance. Owing to genetic constraints, we used flies with only one copy of the rescue construct. Endogenous GFP-LC accumulated in an rLCand Vps28-dependent manner in the fat bodies of flies challenged with dead bacteria (Fig. 6a,b) . Immediately after infection, Relish is cleaved to release the transcriptionally active fragment Rel68 from the inhibitory fragment Rel49. This cleavage was not affected by lack of rLC or Vps28, indicating that early activation of the IMD response was normal (Fig. 6a,b) . At the transcriptional level, accumulation of LC was reflected by significantly (P < 0.001) delayed resolution of the immune response after knockdown of vps28, alone or in combination with loss of the single rescue copy of the gene encoding rLC (Fig. 6c) . Given this observation, it is likely that rLC and Vps28 act in concert to remove LC from the plasma membrane. Indeed, the regulatory function of overexpressed rLCx was significantly (P < 0.001) impaired upon vps28 knockdown ( Fig. 6d and Supplementary  Fig. 5h ), suggesting that rLC acts upstream of Vps28. Consistent with our data, LC was previously shown to interact with the ESCRT protein Vps28 in an S2 cell-based protein interaction network 41 .
As receptor ubiquitination can serve as signal for endocytic trafficking, we tested whether rLC recruits the ubiquitin ligase DIAP2, which acts at multiple steps in the IMD pathway [42] [43] [44] . Indeed, coimmunoprecipitation experiments in S2 cells indicated that rLC bound to DIAP2, and that this interaction required the PHD domain of rLC (Fig. 6e) . Together, these data suggest that resolution of IMD signaling is controlled by rLC-mediated endocytosis and ESCRT-dependent degradation of PGRP-LC (Supplementary Fig. 6 ).
DISCUSSION
PGRP-LC has a clear role as the major signaling receptor sensing Gram-negative bacteria in flies, but its contribution to the resolution phase once bacteria are killed and release polymeric PGN has remained elusive. Here we have uncovered a regulatory isoform of LC (rLC) that adjusts the immune response to the level of threat. We demonstrate that rLC specifically downregulates IMD pathway activation in response to polymeric PGN, a hallmark of efficient bacterial killing. Our data are consistent with a model whereby the presence of rLC leads to efficient endocytosis of LC and termination of signaling via the ESCRT pathway. Trafficking-mediated shutdown of LC-dependent signaling ensures that LC receptors are switched off once the balance is tipped in favor of ligands signifying dead bacteria, allowing Drosophila to terminate a successful immune response. Failure to do so results in over-signaling, leading to the death of the 13 . eGFP does not affect PGRP-LC function 13 . Full-length vectors were digested with SwaI; isoform-specific vectors were digested with SwaI and NheI. The released backbones with parts of the PGRP-LC sequence were gel purified, and the insert was resynthesized in two PCR fragments to lack exon 5. Backbone and ∆ex5 inserts were then reassembled using InFusion cloning (Takara Clontech) and sequenced across the entire PGRP-LC locus. Deletion of exon 5 leaves the flanking intronic sequences intact. Correct constructs were injected by BestGene into BDSC stock number 24482, a second chromosome landing site at 51C validated for previous PGRP-LC constructs 13 . For Gal4-UAS-mediated overexpression in vivo, the coding sequence (CDS) of rPGRP-LCx without a stop codon (for C-terminal fusion constructs) or with a stop codon and 3′ UTR was assembled from DGRC cDNA clone IP15993 and BDGP Gold clone IP15793 using standard PCR fusion and integrated into an entry vector using TOPO cloning (Life Technologies). These two entry vectors were used as templates for all subsequent applications. Small deletions or point mutations were done with the QuikChange site-directed mutagenesis kit (Agilent). Inserts were recombined from entry clones to appropriate Gateway expression vectors (pTW for no tag or entry clone encoded N-terminal GFP tag, pTWM for C-terminal Myc tag, pTWR for C-terminal mRFP tag) by LR Clonase II reaction (Life Technologies). UAS constructs were injected into embryos by BestGene or the Transgenics Facility of CBMSO, University of Madrid, using standard P-element integration.
For copper-inducible expression in Schneider 2 (S2) cells, the CDS of rLCx without 'stop' generated above was transferred into the pMT-V5-His 6 expression vector by restriction digest cloning and subsequently modified as for UAS constructs above. pMT-Pirk-HA, pMT-PGRP-LCx-V5 and pMT-dIAP2-HA have been described 23, 43 .
Infections and immune-response readouts. Infection protocols were done as previously described 13, 51 . We used males for survival and females for all other experiments. Flies were infected by pricking with a tungsten needle dipped in bacterial pellets or by injection with glass capillaries controlled by Nanoject (13.8 nl per fly). Elicitors were E. coli peptidoglycan 0.05 mg/ml (~0.05 mM) and synthetic GlcNAc-1,6-anhydro-MurNAcl-Ala-d-Glu-mesoDAP-d-Ala (TCT) 0.42 mM (a gift from D. MenginLecreulx). The molarity of PGN is determined on the basis of titration of its hydrolyzed component parts (for example, muramic acid, DAP) and refers to monomeric units (1 GlcNac-MurNac-tetrapeptide ~1, 000 Da) in the PGN polymers (personal communication, D. Mengin-Lecreulx). Owing to steric hindrance between PGRP domains, only every fifth monomeric unit can be bound in PGN 52 , lowering the effective binding site concentration fivefold. Erwinia carotovora carotovora strain 15 (Ecc15) and Ecc15-GFP were grown at 29 °C in LB or LB-rifampicin, respectively, and pelleted to OD 600 = 200. E. coli was grown at 37 °C in LB and pelleted to OD 600 = 400. All infection experiments were carried out at 29 °C to optimize bacterial growth. For infections with dead bacteria, bacterial pellets were heat-killed by boiling at 95 °C for 10 min.
Immune responses were quantified as Dpt transcription relative to the ribosomal gene RpL32. All primers used in this study are listed in Supplementary  Table 4 . Total RNA was extracted from 10 females or 15 fat bodies by TriZol, reverse transcribed using Superscript II RT enzyme and random hexamer primers unless otherwise indicated, and qPCR of cDNA was performed on a LightCycler 480 using the SYBR Green kit from Roche. Because of variability between bacterial pellets, occasional batch effects were observed, which increases deviation between samples from different biological repeats of an experiment. To correct for this, where necessary, we normalized all data points of each experiment to an internal control (usually wild-type or driver line) before pooling data from independent experiments.
For bacterial killing, three flies per genotype were collected within 1 h of infection (infectious dose) or at later time points after infection (clearance), and crushed in 150 µl sterile LB. Fourfold serial dilutions of total fly extracts were plated on LB-rifampicin in 3-µl spots, and GFP-positive colonies were counted the next day. The detection limit of this assay is 1 bacterium per 3 µl, or an equivalent of <17 bacteria/fly.
Survival experiments were carried out on batches of 30 males per genotype per tube, and tubes were flipped every 3-4 d.
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Immunoblotting. For quantification of overexpressed GFP-rLCx protein abundance ( Fig. 5f and Supplementary Fig. 5d ), 10 whole flies were directly lysed in 200 µl 2× SDS-PAGE loading buffer. 15 µl total fly lysate were separated on SDS-PAGE, then transferred to nitrocellulose membranes (iBlot, Life Technologies). For quantification of endogenous GFP-LC protein abundance (Figs. 4a and 6a,b) , 10 fat bodies were dissected and lysed in 65 µl RIPA buffer. 25 µl lysate was added to 35 µl 2× SDS-PAGE loading buffer, and 15 µl was loaded per well. Blots were revealed with mouse anti-GFP (1:1,000; clone mix 7.1 and 13.1, 11814460001; Roche), mouse anti-Relish (1:500; 21F3; DSHB) 54 or mouse anti-tubulin (1:2,000; clone DM1A, T9026; Sigma-Aldrich), followed by donkey anti-mouse HRP-coupled secondary antibody (1:2,000; 715-035-150; Jackson ImmunoResearch). ECL (GE Healthcare) was used for detection. The FIJI/ImageJ software suite was used to quantify signal from blots 53 .
S2 cell expression and coimmunoprecipitation. S2 cells were transfected with copper-inducible pMT vectors. Coimmunoprecipitation was carried out as described 23 .
Statistical analysis. All analyses were done with GraphPad Prism. Where more than two groups were compared, one-way or two-way ANOVA with corresponding post hoc tests was used, to correct for multiple comparisons. For non-Gaussian distributions, equivalent nonparametric tests were used. Survival analysis was done by log-rank test. Tests, numbers of experiments and meaning of P values are indicated in each figure legend. 
